HROW
Harrow Health, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$44.45-4.72%
Price as of Jul 20, 2026
HROW profitability
Harrow Health, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 74.1%
- EBITDA margin
- 11.7%
- EBIT margin
- 10.5%
- Net margin
- -5.6%
- Free cash flow margin
- 5.3%
Returns
- Return on equity
- -52.1%
- Return on assets
- -3.6%
- Return on invested capital
- 8.5%
- Asset turnover
- 0.66x
Cash efficiency
- Cash from operations
- $15.2M
- Cash per share
- $2.54
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.